To ensure that an individual who is transitioning from receiving medical treatment furnished by the Secretary of Defense to medical treatment furnished by the Secretary of Veterans Affairs receives the pharmaceutical agents required for such transition.

United States115th CongressHR-1063House of Representatives
Updated: Sep 26, 2017

Summary

Veteran Prescription Continuity Act This bill amends the National Defense Authorization Act for Fiscal Year 2016 to direct the Department of Veterans Affairs (VA) to furnish an individual who is transitioning from Department of Defense (DOD)- to VA-furnished medical treatment any pharmaceutical agent not included in the joint uniform formulary if a DOD health care provider determines that the pharmaceutical agent is critical for the transition. The VA shall furnish an individual with such pharmaceutical agent: (1) beginning when the individual enrolls in the VA health care system, and (2) ending when a DOD health care provider determines that the individual does not require the pharmaceutical agent.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the House Committee on Veterans' Affairs.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Subcommittee Hearings Held.

    House of Representatives

All available records shown.